Deubiquitinase Ubiquitin-Specific Protease 10 Deficiency Regulates Sirt6 signaling and Exacerbates Cardiac Hypertrophy

被引:27
|
作者
Zhang, Dian-Hong [1 ]
Zhang, Jie-Lei [2 ]
Huang, Zhen [1 ]
Wu, Lei-Ming [1 ]
Wang, Zhong-Min [3 ]
Li, Ya-Peng [1 ]
Tian, Xin-Yu [1 ]
Kong, Ling-Yao [1 ]
Yao, Rui [1 ]
Zhang, Yan-Zhou [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Cardiovasc Hosp, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Endocrinol, Zhengzhou, Peoples R China
[3] FuWai Cent China Cardiovasc Hosp, Dept Cardiol, Zhengzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Akt; cardiac hypertrophy; Sirt6; ubiquitin‐ specific protease 10; ACTIVATION; PATHWAYS;
D O I
10.1161/JAHA.120.017751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cardiac hypertrophy (CH) is a physiological response that compensates for blood pressure overload. Under pathological conditions, hypertrophy can progress to heart failure as a consequence of the disorganized growth of cardiomyocytes and cardiac tissue. USP10 (ubiquitin-specific protease 10) is a member of the ubiquitin-specific protease family of cysteine proteases, which are involved in viral infection, oxidative stress, lipid drop formation, and heat shock. However, the role of USP10 in CH remains largely unclear. Here, we investigated the roles of USP10 in CH. Methods and Results Cardiac-specific USP10 knockout (USP10-CKO) mice and USP10-transgenic (USP10-TG) mice were used to examined the role of USP10 in CH following aortic banding. The specific functions of USP10 were further examined in isolated cardiomyocytes. USP10 expression was increased in murine hypertrophic hearts following aortic banding and in isolated cardiomyocytes in response to hypertrophic agonist. Mice deficient in USP10 in the heart exhibited exaggerated cardiac hypertrophy and fibrosis following pressure overload stress, which resulted in worsening of cardiac contractile function. In contrast, cardiac overexpression of USP10 protected against pressure overload-induced maladaptive CH. Mechanistically, we demonstrated that USP10 activation and interaction with Sirt6 in response to angiotensin II led to a marked increase in the ubiquitination of Sirt6 and resulted in Akt signaling downregulation and attenuation of cardiomyocyte hypertrophy. Accordingly, inactivation of USP10 reduced Sirt6 abundance and stability and diminished Sirt6-induced downstream signaling in cardiomyocytes. Conclusions USP10 functions as a Sirt6 deubiquitinase that induces cardiac myocyte hypertrophy and triggers maladaptive CH.
引用
收藏
页数:15
相关论文
共 39 条
  • [1] Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy
    Liu, Li-Bo
    Huang, Si-Hui
    Qiu, Hong-Liang
    Cen, Xian-Feng
    Guo, Ying-Ying
    Li, Dan
    Ma, Yu-Lan
    Xu, Man
    Tang, Qi-Zhu
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (18) : 4516 - 4533
  • [2] Ubiquitin-specific protease 14 regulates cardiac hypertrophy progression by increasing GSK-3β phosphorylation
    Liu, Ningning
    Chai, Renjie
    Liu, Bin
    Zhang, Zhenhui
    Zhang, Shuangwei
    Zhang, Jingzhi
    Liao, Yuning
    Cai, Jianyu
    Xia, Xiaohong
    Li, Aiqun
    Liu, Jinbao
    Huang, Hongbiao
    Liu, Shiming
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (03) : 1236 - 1241
  • [3] Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy
    He, Ben
    Zhao, Yi-Chao
    Gao, Ling-Chen
    Ying, Xiao-Ying
    Xu, Long-Wei
    Su, Yuan-Yuan
    Ji, Qing-Qi
    Lin, Nan
    Pu, Jun
    HYPERTENSION, 2016, 67 (06) : 1237 - +
  • [4] Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6
    Luo, Pengcheng
    Qin, Cong
    Zhu, Lihua
    Fang, Chun
    Zhang, Yan
    Zhang, Hai
    Pei, Fei
    Tian, Song
    Zhu, Xue-Yong
    Gong, Jun
    Mao, Qing
    Xiao, Chengcheng
    Su, Yang
    Zheng, Haizhou
    Xu, Tao
    Lu, Jingxiao
    Zhang, Jie
    HEPATOLOGY, 2018, 68 (05) : 1786 - 1803
  • [5] Deubiquitinase Ubiquitin-Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β-Activated Kinase 1
    Jiang, Xi
    Sun, Yan
    Shi, Hongjie
    Liu, Zhen
    Zhang, Jianqing
    Xu, Changlu
    Hu, Yufeng
    Niu, Tiesheng
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
  • [6] Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling
    Min Liu
    Kaili Liang
    Junhui Zhen
    Meng Zhou
    Xiaojie Wang
    Ziying Wang
    Xinbing Wei
    Yan Zhang
    Yu Sun
    Zhuanli Zhou
    Hua Su
    Chun Zhang
    Ningjun Li
    Chengjiang Gao
    Jun Peng
    Fan Yi
    Nature Communications, 8
  • [7] Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling
    Liu, Min
    Liang, Kaili
    Zhen, Junhui
    Zhou, Meng
    Wang, Xiaojie
    Wang, Ziying
    Wei, Xinbing
    Zhang, Yan
    Sun, Yu
    Zhou, Zhuanli
    Su, Hua
    Zhang, Chun
    Li, Ningjun
    Gao, Chengjiang
    Peng, Jun
    Yi, Fan
    NATURE COMMUNICATIONS, 2017, 8
  • [8] Ubiquitin-Specific Protease 13 Regulates IFN Signaling by Stabilizing STAT1
    Yeh, Hom-Ming
    Yu, Chia-Yi
    Yang, Ho-Chun
    Ko, Shih-Han
    Liao, Ching-Len
    Lin, Yi-Ling
    JOURNAL OF IMMUNOLOGY, 2013, 191 (06): : 3328 - 3336
  • [9] The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling
    Yu, Samuel Mon-Wei
    Jean-Charles, Pierre-Yves
    Abraham, Dennis M.
    Kaur, Suneet
    Gareri, Clarice
    Mao, Lan
    Rockman, Howard A.
    Shenoy, Sudha K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (07) : 2500 - 2518
  • [10] The Ubiquitin-Specific Protease USP34 Regulates Axin Stability and Wnt/β-Catenin Signaling
    Lui, Tony T. H.
    Lacroix, Celine
    Ahmed, Syed M.
    Goldenberg, Seth J.
    Leach, Craig A.
    Daulat, Avais M.
    Angers, Stephane
    MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (10) : 2053 - 2065